First use of model predictive control in outpatient wearable artificial pancreas

Diabetes Care

Volumn 37, Issue 5, 2014, Pages 1212-1215

  Del Favero, Simone ^a   Bruttomesso, Daniela ^a   Di Palma, Federico ^b   Lanzola, Giordano ^b   Visentin, Roberto ^a   Filippi, Alessio ^d   Scotton, Rachele ^a   Toffanin, Chiara ^b   Messori, Mirko ^b   Scarpellini, Stefania ^b   Keith Hynes, Patrick ^c   Kovatchev, Boris P ^c   DeVries, J Hans ^d   Renard, Eric ^e   Magni, Lalo ^b   Avogaro, Angelo ^a   Cobelli, Claudio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; ALGORITHM; ARTICLE; ARTIFICIAL PANCREAS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROL SYSTEM; GLUCOSE SENSOR; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MODEL PREDICTIVE CONTROL; OUTPATIENT; POSTPRANDIAL STATE; BLOOD; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN INFUSION; MALE; METABOLISM; TREATMENT OUTCOME;

ADULT; ALGORITHMS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; PANCREAS, ARTIFICIAL; POSTPRANDIAL PERIOD; TREATMENT OUTCOME;

EID: 84899108319     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1631     Document Type: Article

References (13)

1. Cobelli C, Renard E, Kovatchev B. Artificial pancreas: past, present, future. Diabetes 2011;60:2672-2682
2. Cobelli C, Renard E, Kovatchev BP, et al. Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care 2012;35:e65-e67
3. Kovatchev BP, Renard E, Cobelli C, et al. Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care 2013;36:1851-1858
4. Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368:824-833
5. Keith-Hynes P, Guerlain S, Mize B, et al. DiAs user interface: a patient-centric interface for mobile artificial pancreas systems. J Diabetes Sci Technol 2013;7:1416-1426
6. Capozzi D, Lanzola G. A generic telemedicine infrastructure for monitoring an artificial pancreas trial. Comput Methods Programs Biomed 2013;110:343-353
7. Soru P, De Nicolao G, Toffanin C, Dalla Man C, Cobelli C, Magni L; on behalf of the AP@home consortium. MPC based artificial pancreas: strategies for individualization and meal compensation. Annu Rev Contr 2012;36:118-128
8. Patek SD, Magni L, Dassau E, et al.; International Artificial Pancreas (iAP) Study Group. Modular closed-loop control of diabetes. IEEE Trans Biomed Eng 2012;59:2986-2999
9. Magni L, Raimondo DM, Bossi L, et al. Model predictive control of type 1 diabetes: an in silico trial. J Diabetes Sci Tech 2007;1:804-812
10. Breton M, Farret A, Bruttomesso D, et al.; International Artificial Pancreas Study Group. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes 2012;61:2230-2237
11. Beck RW, Calhoun P, Kollman C. Challenges for outpatient closed loop studies: how to assess efficacy. Diabetes Technol Ther 2013;15:1-3
12. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke WL. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care 1998;21:1870-1875 (Pubitemid 28478285)
13. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Clarke WL. Methods for quantifying self-monitoring blood glucose profiles exemplified by an examination of blood glucose patterns in patients with type 1 and type 2 diabetes. Diabetes Technol Ther 2002;4:295-303 (Pubitemid 34666277)